News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bio Usawa and Sartorius Stedim Biotech Partner to Advance Biopharmaceutical Manufacturing in Africa
Wednesday, July 30, 2025Bio Usawa Biotechnology Ltd an African biotechnology company has partnered with Sartorius Stedim Biotech a global biopharmaceutical manufacturing solutions provider to strengthen Africas biopharmaceutical sector
Calidi Biotherapeutics Granted FDA Fast Track Designation for CLD-201, an Innovative Viral Therapy for Soft Tissue Sarcoma
Wednesday, July 30, 2025Calidi Biotherapeutics Inc a clinicalstage biotechnology company focused on developing targeted treatments using genetic medicine delivery systems has received Fast Track designation from the US Food and Drug Administration FDA
Zymeworks Receives FDA Clearance for Investigational Drug ZW251 to Treat Liver Cancer
Tuesday, July 29, 2025Zymeworks Inc a clinicalstage biotechnology company has announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for ZW
Boehringer Ingelheim and Re-Vana Therapeutics Partner to Develop Long-Acting Eye Treatments
Tuesday, July 29, 2025Boehringer Ingelheim has entered into a strategic collaboration and licensing agreement with ReVana Therapeutics a company based in the US and UK that specialises in ocular therapies and drug delivery technologies
Sarclisa Gains EU Approval for Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients
Friday, July 25, 2025Sanofi has received approval from the European Commission for the use of Sarclisa isatuximab in combination with bortezomib lenalidomide and dexamethasone VRd as an induction treatment for adults newly diagnosed
Candel Therapeutics Gains EMA Orphan Designation for CAN-2409 in Pancreatic Cancer Treatment
Friday, July 25, 2025Candel Therapeutics a clinicalstage biopharmaceutical company has been granted Orphan Designation by the European Medicines Agency EMA for its investigational therapy CAN aglatimagene besadenovec
Solid Biosciences Secures FDA Fast Track Designation for Gene Therapy Candidate SGT-501 Targeting CPVT
Thursday, July 24, 2025Solid Biosciences has received Fast Track designation from the US Food and Drug Administration FDA for SGT its investigational gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia
New England Biolabs Launches Low-Bias Small RNA Library Prep Kit to Improve RNA Diversity Analysis
Wednesday, July 23, 2025New England Biolabs NEB has introduced the NEBNext Lowbias Small RNA Library Prep Kit a new solution designed to reduce bias in small RNA sequencing and better reflect the true diversity of RNA species in research samples
Longeveron® Licences New Cardiac-Targeted Stem Cell Technology for Heart Disease
Tuesday, July 22, 2025Longeveron Inc a clinicalstage biotechnology company focused on regenerative medicine has licensed a newly issued US patent B from the University of Miami The patent covers a specialised stem cell technology
ImCheck Receives EMA Orphan Drug Designation for ICT01 in Acute Myeloid Leukaemia
Tuesday, July 22, 2025ImCheck Therapeutics has received Orphan Drug Designation ODD from the European Medicines Agency EMA for its lead candidate ICT aimed at treating acute myeloid leukaemia AML ICT is a humanised monoclonal
